As on September 10, 2020, Abbott Laboratories (NYSE: ABT) started slowly as it slid -1.71% to $104.00. During the day, the stock rose to $105.60 and sunk to $103.73 before settling in for the price of $105.81 at the close. Taking a more long-term approach, ABT posted a 52-week range of $61.61-$114.19.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 9.50%. Meanwhile, its Annual Earning per share during the time was 12.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 45.20%. This publicly-traded company’s shares outstanding now amounts to $1.77 billion, simultaneously with a float of $1.76 billion. The organization now has a market capitalization sitting at $186.56 billion. At the time of writing, stock’s 50-day Moving Average stood at $100.41, while the 200-day Moving Average is $90.18.
If we measure the efficiency of the company that is accounted for 107000 employees. It has generated 298,168 per worker during the last fiscal year. Meanwhile, its income per employee was 34,262. The stock had 6.02 Receivables turnover and 0.47 Total Asset turnover. For the Profitability, stocks gross margin was +52.32, operating margin was +14.39 and Pretax Margin of +12.78.
Abbott Laboratories (ABT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Abbott Laboratories’s current insider ownership accounts for 0.70%, in contrast to 75.70% institutional ownership. According to the most recent insider trade that took place on Sep 01, this organization’s Senior Vice President sold 6,290 shares at the rate of 108.73, making the entire transaction reach 683,929 in total value, affecting insider ownership by 56,630. Preceding that transaction, on Aug 27, Company’s Executive Vice President sold 42,479 for 111.86, making the whole transaction’s value amount to 4,751,701. This particular insider is now the holder of 102,433 in total.
Abbott Laboratories (ABT) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 6/29/2020, the company posted $0.57 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $0.42) by $0.15. This company achieved a net margin of +11.49 while generating a return on equity of 11.90. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.18 per share during the current fiscal year.
Abbott Laboratories’s EPS increase for this current 12-month fiscal period is 45.20% and is forecasted to reach 4.04 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.90% through the next 5 years, which can be compared against the 12.40% growth it accomplished over the previous five years trading on the market.
Abbott Laboratories (NYSE: ABT) Trading Performance Indicators
Let’s observe the current performance indicators for Abbott Laboratories (ABT). It’s Quick Ratio in the last reported quarter now stands at 1.10. The Stock has managed to achieve an average true range (ATR) of 2.90. Alongside those numbers, its PE Ratio stands at $60.15, and its Beta score is 0.93. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.93. Similarly, its price to free cash flow for trailing twelve months is now 86.89.
In the same vein, ABT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.73, a figure that is expected to reach 0.89 in the next quarter, and analysts are predicting that it will be 4.04 at the market close of one year from today.
Technical Analysis of Abbott Laboratories (ABT)
Through scrutinizing the latest numbers posted by the [Abbott Laboratories, ABT], it can be observed that its last 5-days Average volume of 5.0 million was lower the volume of 7.53 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 18.14% While, its Average True Range was 3.20.
Raw Stochastic average of Abbott Laboratories (ABT) in the period of the previous 100 days is set at 63.63%, which indicates a major rise in contrast to 24.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 43.18% that was higher than 30.64% volatility it exhibited in the past 100-days period.